Bericht

Analysis of COVID-related patents for antibodies and vaccines

This paper provides an analysis of patents covering selected antibodies and vaccines used in the treatment or prevention of COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the examination of the claims contained in relevant patents or patent applications. The antibody combination considered for the patent analysis in this paper are Casirivimab and Imdevimab. The vaccines considered for the patent analysis are mRNA-1273, Sputnik, ChAdOx1 nCoV-19 vaccine (AZD1222). The analysis was completed in May 2022.

Sprache
Englisch

Erschienen in
Series: Research Paper ; No. 173

Klassifikation
Sozialwissenschaften, Soziologie, Anthropologie
Thema
Access to Medicines
Antibodies
COVID-19
Global Health
Health
Intellectual Property
Pandemic
Patent
Patent Examination
Patent Law
Patent Offices
Patent Policy
Patent Protection
Public Health
Vaccines

Ereignis
Geistige Schöpfung
(wer)
Santhanam, Kausalya
Ereignis
Veröffentlichung
(wer)
South Centre
(wo)
Geneva
(wann)
2023

Handle
Letzte Aktualisierung
10.03.2025, 11:45 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Objekttyp

  • Bericht

Beteiligte

  • Santhanam, Kausalya
  • South Centre

Entstanden

  • 2023

Ähnliche Objekte (12)